EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Marca de levotiroxina y requerimientos de dosis ajustada por peso en el hipotiroidismo primario: evidencia del mundo real de diferencias en dosis sin variación farmacodinámica

Paula Nasazzi Doddi, Rodolfo Néstor Feldman, Estefanía Pustilnik, Diamela Bolzan, Luis Agustín Ramírez Stieben

EndoAr · 26.06.2026 · 2 (2) · 147-158

DOI: 10.65640/6thh8x79 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EndoAr, online erschienen am 26.06.2026. Verfasst von Paula Nasazzi Doddi und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levothyroxine (LT4) is commonly considered interchangeable across brands, yet small formulation differences may translate into different dose requirements in routine care. We compared three LT4 brands in adults with biochemically controlled hypothyroidism, focusing on weight-adjusted dose needed to maintain normal TSH and pharmacodynamic response. Materials and methods: observational cross-sectional study using a private outpatient database. Adults with primary hypothyroidism, TSH within the reference range, and etiology limited to Hashimoto’s thyroiditis or post-thyroidectomy were included. Exposure was LT4 brand (A, B, C). Primary outcome was LT4 dose per kg (µg/kg/day). Pharmacodynamic outcome was log-transformed TSH modeled as a function of brand, dose per kg, age, sex, and etiology. Robust standard errors and propensity score-based inverse probability of treatment weighting (IPTW) were used to address confounding by non-random brand assignment. Brand×etiology interaction was explored. Results: we included 274 adults (A n=102, B n=152, C n=20). In adjusted models, brand was associated with dose per kg; Brand A required a higher dose than Brand B (adjusted difference ≈0.14 µg/kg/day), while comparisons involving Brand C were imprecise and non-significant. Dose per kg decreased with age and was higher in post-thyroidectomy. In pharmacodynamic models, brand was not associated with log(TSH) after adjustment (global p=0.58), and results were consistent in IPTW-weighted analyses (global p=0.68). No significant brand×etiology interaction was detected. Discussion: LT4 brand was associated with small differences in weight-adjusted dose requirements, but not with adjusted TSH response. These observational findings should be interpreted cautiously and support biochemical monitoring when treatment changes occur.

Zitieren

APA

Doddi, P. N., Feldman, R. N., Pustilnik, E., Bolzan, D., & Stieben, L. A. R. (2026). Marca de levotiroxina y requerimientos de dosis ajustada por peso en el hipotiroidismo primario: evidencia del mundo real de diferencias en dosis sin variación farmacodinámica. EndoAr, 2(2), 147-158. https://doi.org/10.65640/6thh8x79

Vancouver

Doddi PN, Feldman RN, Pustilnik E, Bolzan D, Stieben LAR. Marca de levotiroxina y requerimientos de dosis ajustada por peso en el hipotiroidismo primario: evidencia del mundo real de diferencias en dosis sin variación farmacodinámica. EndoAr. 2026;2(2):147-158. doi:10.65640/6thh8x79

BibTeX
@article{Doddi2026,
  author = {Doddi, Paula Nasazzi and Feldman, Rodolfo Néstor and Pustilnik, Estefanía and Bolzan, Diamela and Stieben, Luis Agustín Ramírez},
  title = {Marca de levotiroxina y requerimientos de dosis ajustada por peso en el hipotiroidismo primario: evidencia del mundo real de diferencias en dosis sin variación farmacodinámica},
  journal = {EndoAr},
  year = {2026},
  volume = {2},
  number = {2},
  pages = {147--158},
  doi = {10.65640/6thh8x79}
}
Kostenlos starten →